Sales of Spectrum's drug Fusilev for patients with metastatic colorectal cancer remain strong heading into the remainder of 2014.
Stocks with higher levels of hedge fund ownership displayed higher relative returns in a study, said Erin Gibbs, Equity Chief Investment Officer for S&P Capital IQ.
Global business consultants have seen their share prices stagnate partly due to geopolitical volatility, said NV 'Tiger' Tyagarajan, CEO of Genpact.
Shares of Regeneron and Sanofi are opening the week higher after revealing an experimental cholesterol-lowering drug nearly halved the number of heart attacks and strokes in a clinical trial.
AMC’s "Breaking Bad" was the big winner at the Emmy’s this week, taking home the award for best drama series.
Dollar Geneal posted second quarter earnings of $0.83 a share on revenue of $4.72 billion.
Williams-Sonoma posted second quarter earnings of $0.53 a share on revenue of $1.04 billion.
Demand for bigger and brighter video displays at NFL stadiums and NBA arenas will keep Daktronics pipeline full in the second half of 2014, said the company's CEO Reece Kurtenbach.
AMN Healthcare Services shares and results have bounced back in the past quarter because hospital managers have become more confident about their staffing needs, said AMN's CEO Susan Salka.
The M&A boom makes this a great time to be an entrepreneur if you have a solid business plan and an exit strategy.